Mardi Dier - Jun 12, 2025 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Director
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
Stock symbol
PRLD
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 04:15 PM
Previous filing
Mar 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dier Mardi Director C/O PRELUDE THERAPEUTICS INCORPORATED, 175 INNOVATION BOULEVARD, WILMINGTON /s/ Krishna Vaddi, Attorney-in-Fact 2025-06-13 0001574591

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Director Stock Option (Right to Buy) Award $0 +38K $0.00 38K Jun 12, 2025 Common Stock 38K $1.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award will fully vest upon the earlier of (a) the Issuer's next annual stockholder meeting, or (b) the one-year anniversary of the grant date, such to the Reporting Person's provision of service to the Issuer on each vesting date.